Lafora-Like Ground-Glass Inclusions in Hepatocytes of Pediatric Patients: A Report of Two Cases

Abstract

We report 2 cases of ground-glass hepatocyte inclusions occurring in pediatric patients. Case 1 had alpha-thalassaemia major and was receiving iron chelation therapy, whereas case 2 had trisomy 21 with a history of bone marrow transplantation for acute myeloid leukemia. The liver sections in both cases showed eosinophilic, periodic acid-Schiff diastase—positive intracytoplasmic inclusions that were negative for hepatitis B surface antigen. Immunohistochemically the inclusions showed positive staining with KM279, a monoclonal antibody against polyglucosan derived from Lafora inclusions. On electron microscopy, in case 1, intracytoplasmic inclusions were composed of degenerate organelles, glycogen, and irregular fibrillar structures; in case 2, they were composed of vesicular structures containing granular material. Ultrastructural changes in both cases differed from classical Lafora inclusions and ruled out hepatitis B surface antigen, glycogenosis type IV, and fibrinogen storage disease. Genetic analysis of the Lafora's disease genes performed in case 2 revealed no mutations. The development of hepatocyte cytoplasmic inclusions in both our cases could be related to medication effects, because similar inclusions were reported in patients using cyanamide. Drug-induced inclusions, mimicking Lafora's disease, should be included in the differential diagnosis of hepatocyte ground-glass inclusions.

Keywords

ground-glass inclusions Lafora's disease liver medication pediatric

Get full access to this article

View all access options for this article.

References

Hadziyannis

Gerber

Vissoulis

Popper

. Cytoplasmic hepatitis B antigen in “ground-glass” hepatocytes of carriers. Arch Pathol 1973;96(5):327–330.

Cajal

Blanes

Martinez

Saenz

Gutierrez

. Lafora's disease: an ultrastructural and histochemical study. Acta Neuropathol (Berl) 1974;30(3):189–196.

Schochet

Jr. McCormick

Zellweger

. Type IV glycogenosis (amylopectinosis): light and electron microscopic observations. Arch Pathol 1970;90(4):354–363.

Callea

de Vos

Togni

Tardanico

Vanstapel

Desmet

. Fibrinogen inclusions in liver cells: a new type of ground-glass hepatocyte. Immune light and electron microscopic characterization. Histopathology 1986;10(1):65–73.

Thomsen

Reinicke

. Ground glass inclusions in liver cells in an alcoholic treated with cyanamide (Dipsan). Liver 1981;1(1):67–73.

Vazquez

Cervera

. Cyanamide-induced liver injury in alcoholics. Lancet 1980;1(8164):361–362.

Vazquez

. Ground-glass hepatocytes: light and electron microscopy. Characterization of the different types. Histol Histopathol 1990;5(3):379–386.

Yokota

Ishihara

Yoshida

Takahashi

Uchino

Hamanaka

. Monoclonal antibody against polyglucosan isolated from the myocardium of a patient with Lafora disease. J Neuropathol Exp Neurol 1988;47(5):572–577.

Hashimoto

Hoshii

Takahashi

. Use of a monoclonal antibody against Lafora bodies for the immunocytochemical study of ground-glass inclusions in hepatocytes due to cyanamide. Histopathology 2001;39(1):60–65.

10.

Selby

Rudzki

Bayever

Chandra

. Vasculopathy of small muscular arteries in pediatric patients after bone marrow transplantation. Hum Pathol 1999;30(7):734–740.

11.

Kawata

Seki

Minami

. Morphological changes of the liver in uremic patients treated with chronic hemodialysis: laparoscopic observations and light- and electron-microscopic studies. Gastroenterol Jpn 1980;15(3):212–220.

12.

Kanel

Uchida

Peters

. Globular hepatic amyloid: an unusual morphologic presentation. Hepatology 1981;1(6):647–652.

13.

French

Schloss

Stillman

. Unusual amyloid bodies in human liver. Am J Clin Pathol 1981;75(3):400–402.

14.

Sturgess

Williams

Portmann

. Ground-glass hepatocytes with Lafora body like inclusions: histochemical, immunohistochemical and electronmicroscopic characterization. Histopathology 1990;17(2):109–115.

15.

Singer

Styles

Bojanowski

Quirolo

Foote

Vichinsky

. Changing outcome of homozygous alpha-thalassemia: cautious optimism. J Pediatr Hematol Oncol 2000;22(6):539–542.

16.

Bottomley

. Secondary iron overload disorders. Semin Hematol 1998;35(1):77–86.

17.

Schrier

Angelucci

. New strategies in the treatment of the thalassemias. Annu Rev Med 2005;56:157–171.

18.

Britton

Leicester

Bacon

. Iron toxicity and chelation therapy. Int J Hematol 2002;76(3):219–228.

19.

Thakerngpol

Fucharoen

Boonyaphipat

. Liver injury due to iron overload in thalassemia: histopathologic and ultrastructural studies. Biometals 1996;9(2):177–183.

20.

Iancu

Deugnier

Halliday

Powell

Brissot

. Ultrastructural sequences during liver iron overload in genetic hemochromatosis. J Hepatol 1997;27(4):628–638.

21.

Zubair

Herrera

Pretlow

Roper

Zornes

. Cytoplasmic inclusions in hepatocytes of bone marrow transplant patients: light and electron microscopic characterization. Am J Clin Pathol 1985;83(1):65–68.

22.

Wisell

Boitnott

Haas

. Glycogen pseudoground glass change in hepatocytes. Am J Surg Pathol 2006;30(9):1085–1090.

23.

Lefkowitch

Lobritto

Brown

Jr . Ground-glass, polyglucosan-like hepatocellular inclusions: a “new” diagnostic entity. Gastroenterology 2006;131(3):713–718.

24.

Baumann

Kocoshis

Wilson

. Lafora disease: liver histopathology in presymptomatic children. Ann Neurol 1983;14(1):86–89.

25.

Odor

Janeway

Pearce

Ravens

. Progressive myoclonus epilepsy with Lafora inclusion bodies. II. Studies of ultrastructure. Arch Neurol 1967;16(6):583–594.

26.

Minassian

. Lafora's disease: towards a clinical, pathologic, and molecular synthesis. Pediatr Neurol 2001;25(1):21–29.

27.

Guillen

Vazquez

. Cyanamide-induced liver cell injury: experimental study in the rat. Lab Invest 1984;50(4):385–393.

28.

Lohi

Ianzano

Zhao

. Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy. Hum Mol Genet 2005;14(18):2727–2736.